SABBY MANAGEMENT, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2021$712,000
-63.8%
137,239
-54.3%
0.10%
-60.9%
Q3 2021$1,965,000
-26.0%
300,000
-25.0%
0.27%
-28.9%
Q2 2021$2,656,000
-11.8%
400,050
-23.8%
0.37%
-36.2%
Q1 2021$3,010,000525,2300.59%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders